Telomir Pharmaceuticals, Inc.
TELO
$2.00
$0.042.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 403.00K | 1.27M | 834.60K | 1.88M | 3.27M |
| Total Receivables | -- | -- | -- | 130.00K | 130.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 88.20K | 57.90K | 77.30K | 87.80K | 98.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 130.00K | -- | -- |
| Total Current Assets | 491.20K | 1.32M | 1.04M | 2.10M | 3.50M |
|
|
|||||
| Total Current Assets | 491.20K | 1.32M | 1.04M | 2.10M | 3.50M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 491.20K | 1.32M | 1.04M | 2.10M | 3.50M |
|
|
|||||
| Total Accounts Payable | 558.90K | 587.50K | 506.50K | 393.80K | 221.60K |
| Total Accrued Expenses | -- | -- | -- | -- | 7.40K |
| Short-term Debt | 93.40K | 93.40K | 93.40K | 140.30K | 7.90K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 249.70K |
| Total Other Current Liabilities | -- | -- | -- | -- | 249.70K |
| Total Current Liabilities | 652.30K | 681.00K | 599.90K | 534.20K | 486.60K |
|
|
|||||
| Total Current Liabilities | 652.30K | 681.00K | 599.90K | 534.20K | 486.60K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 93.40K | 93.40K | 93.40K | 140.30K | 7.90K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 652.30K | 681.00K | 599.90K | 534.20K | 486.60K |
|
|
|||||
| Common Stock & APIC | 32.62M | 31.24M | 28.14M | 23.34M | 23.34M |
| Retained Earnings | -32.78M | -30.60M | -27.70M | -21.77M | -20.32M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -161.10K | 643.00K | 442.10K | 1.57M | 3.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -161.10K | 643.00K | 442.10K | 1.57M | 3.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -161.10K | 643.00K | 442.10K | 1.57M | 3.02M |
|
|
|||||